The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: Comparison between PET/CT taken after completion of adjuvant Durvalumab

Not Applicable

• Conditions: non small cell lung cancer

• Registration Number: JPRN-UMIN000050438
• Lead Sponsor: Juntendo University Faculty of Medicine Urayasu Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-05-01
• Last Update Posted: 17 October 2023
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with any component of small cell lung carcinomaPatients with evidence of a malignant pleural or pericardial effusion Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years Prior systemic chemotherapy for the studied cancer (prior chemotherapy for a different cancer is allowable) Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fieldsSevere, active co-morbidity, defined as follows: Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months Transmural myocardial infarction within the last 6 months Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects Acquired immune deficiency syndrome based upon current Centres for Disease Control definition Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception Poorly controlled diabetes (defined as fasting glucose level > 200 mg/dL) despite attempts to improve glucose control by fasting duration and adjustment of medications Patients with T4 disease with radiographic evidence of massive invasion of a large pulmonary artery and tumour causing significant narrowing and destruction of that artery

Study & Design

• Study Type: Interventional
• Study Design: Not specified